A Systematic Review of the Definitions, Prevalence, and Response to Treatment of Nocturnal Gastroesophageal Reflux Disease

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 4, 2009, Pages 372-378

  Gerson, Lauren B ^a   Fass, Ronnie ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE;

ADD ON THERAPY; ASTHMA; BARRETT ESOPHAGUS; CLINICAL TRIAL; DRUG FORMULATION; EVENING DOSAGE; FATIGUE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; INFORMATION RETRIEVAL; MEAL; MORNING DOSAGE; PREVALENCE; QUALITY OF LIFE; REFLUX ESOPHAGITIS; REVIEW; SLEEP; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP PARAMETERS; SLEEP PATTERN; STOMACH ACID; STOMACH FUNDOPLICATION; SYSTEMATIC REVIEW; TREATMENT RESPONSE; WORK DISABILITY;

FEMALE; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; PREVALENCE; PROTON PUMP INHIBITORS; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 62849084044     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.11.021     Document Type: Review

References (68)

1. A Gallup Survey on Heartburn Across America (1988), The Gallup Organization, Princeton, NJ
2. Nebel O.T., Forbes M.F., and Castell D.O. Symptomatic GE reflux: incidence and precipitating factors. Am J Dig Dis 21 (1976) 953-956
3. Johnson L.F., DeMeester T., and Haggit R.C. Esophageal epithelial response to gastroesophageal reflux: a quantitative study. Am J Dig Dis 23 (1978) 498-509
4. Johnson L.F., and DeMeester T. Evaluation of elevation of the head of the bed, bethanechol, and antacid form tablets on gastroesophageal reflux. Dig Dis Sci 26 (1981) 673-680
5. DeMeester T.R., Johnson L., and Kent A.H. Evaluation of current operations for the prevention of gastroesophageal reflux. Ann Surg 180 (1974) 511-523
6. de Caestecker J.S., Pryde A., and Heading R.C. Daytime gastro-oesophageal reflux is important in oesophagitis. Gut 28 (1987) 519-526
7. Johnson L.F., and Harmon J.W. Experimental esophagitis in a rabbit model: clinical relevance. J Clin Gastroenterol 8 Suppl 1 (1986) 26-44
8. Frazzoni M., De Micheli E., and Savarino V. Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non-erosive reflux disease. Aliment Pharmacol Ther 18 (2003) 1091-1098
9. Adachi K., Fujishiro H., Yuki M., et al. Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis. J Gastroenterol Hepatol 16 (2001) 1191-1196
10. Shaker R., Castell D.O., Schoenfeld P.S., et al. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol (2003) 1487-1493
11. Farup C., Kleinman L., Sloan S., et al. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med (2001) 45-52
12. Johnson L.F., and DeMeester T. Twenty-four-hour pH monitoring of the distal esophagus: a quantitative measure of gastroesophageal reflux. Am J Gastroenterol 62 (1974) 325-332
13. Fass R., Fennerty M.B., Ofman J.J., et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 115 (1998) 42-49
14. Hill A. The environment and disease: association or causation?. Proc R Soc Med 58 (1965) 295-300
15. Fass R., Quan S.F., O'Connor G.R., et al. Predictors of heartburn during sleep in a large prospective cohort study. Chest 127 (2005) 1658-1666
16. Dubois R.W., Aguilar D., Fass R., et al. Consequences of frequent nocturnal gastro-oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivity. Aliment Pharmacol Ther 25 (2007) 487-500
17. Bruley des Varannes S., Errieau G., and Tessier C. Two thirds of patients with gastroesophageal reflux have nocturnal symptoms: survey by 562 general practitioners of 36,663 patients. Presse Med 36 (2007) 591-597
18. Orr W.C., Lackey C., Robinson M.G., et al. Esophageal acid clearance during sleep in patients with Barrett's esophagus. Dig Dis Sci 33 (1988) 654-659
19. Dickman R., Parthasarathy S., Malagon I.B., et al. Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups. Aliment Pharmacol Ther 26 (2007) 41-48
20. Hila A., and Castell D. Nighttime reflux is primarily an early event. J Clin Gastroenterol 39 (2005) 579-583
21. Gerson L.B., Bopari V., Ullah N., et al. Oesophageal and gastric pH profiles in patients with gastro-esophggeal reflux disease and Barrett's esophagus treated with proton pump inhibitors. Aliment Pharmacol Ther 20 (2004) 637-643
22. DeVault K.R., and Castell D.O. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100 (2005) 190-200
23. Orr W.C., and Harnish M. Sleep-related gastro-oesophageal reflux: provocation with a late evening meal and treatment with acid suppression. Aliment Pharmacol Ther 12 (1998) 1033-1038
24. Piesman M., Hwang I., Maydonovitch C., et al. Nocturnal acid reflux episodes following the administration of a standardized meal: does timing matter?. Am J Gastroenterol 102 (2007) 1-7
25. Fujiwara Y., Machida A., Watanabe Y., et al. Association between dinner-to-bed time and gastro-esophageal reflux disease. Am J Gastroenterol 100 (2005) 2633-2636
26. Sontag S., O'Connell S., Miller T.Q., et al. Asthmatics have more nocturnal gasping and reflux symptoms than nonasthmatics, and they are related to bedtime eating. Am J Gastroenterol 99 (2004) 789-796
27. Gislason T., Janson C., Vermeire P., et al. Respiratory symptoms and nocturnal gastroesophageal reflux: a population-based study of young adults in three European countries. Chest 121 (2002) 158-163
28. Landstra A.M., Postma D.S., Boezen H.M., et al. Role of serum cortisol levels in children with asthma. Am J Respir Crit Care Med 165 (2002) 708-712
29. Orr W.C., Elsenbruch S., Harnish M.J., et al. Proximal migration of esophageal acid perfusions during waking and sleep. Am J Gastroenterol 95 (2000) 37-42
30. Orr W.C., Allen M.L., and Robinson M. The pattern of nocturnal and diurnal esophageal acid exposure in the pathogenesis of erosive mucosal damage. Am J Gastroenterol 89 (1994) 509-512
31. Dickman R., Parthasarathy S., Malagon I.B., et al. Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups. Aliment Pharmacol Ther 26 (2007) 41-48
32. Ing A.J., Ngu M.C., and Breslin A. Obstructive sleep apnea and gastro-esophageal reflux. Am J Med 108 (2000) 120S-125S
33. Guda N., Partington S., and Vakil N. Symptomatic gastro-esophageal reflux, arousals and sleep quality in patients undergoing polysomnography for possible obstructive sleep apnoea. Aliment Pharmacol Ther 20 (2004) 1153-1159
34. Kim H.N., Vorona R.D., Winn M.P., et al. Symptoms of gastro-oesophageal reflux disease and the severity of obstructive sleep apnoea syndrome are not related in sleep disorder center patients. Aliment Pharmacol Ther 21 (2005) 1127-1133
35. Penzel T., Becker H.F., Brandenburg U., et al. Arousal in patients with gastro-oesophageal reflux and sleep apnoea. Eur Respir J 14 (1999) 1266-1270
36. Morse C.A., Quan S.F., Mays M.Z., et al. Is there a relationship between obstructive sleep apnea and gastroesophageal reflux disease?. Clin Gastroenterol Hepatol 2 (2004) 761-768
37. Kerr P., Shoenut J.P., Millar T., et al. Nasal CPAP reduces gastroesophageal reflux in obstructive sleep apnea syndrome. Chest 101 (1992) 1539-1544
38. Green B.T., Broughton W.A., and O'Connor J. Marked improvement in nocturnal gastroesophageal reflux disease in a large cohort of patients with sleep apnea treated with continuous positive airway pressure. Arch Intern Med 163 (2003) 41-45
39. Konermann M., Radu H.J., Teschler H., et al. Interaction of sleep disturbances and gastroesophageal reflux in chronic laryngitis. Am J Otolaryngol 23 (2002) 20-26
40. Sears Jr. V.W., Castell J.A., and Castell D.O. Comparison of effects of upright versus supine body position and liquid versus solid bolus on esophageal pressures in normal humans. Dig Dis Sci 35 (1990) 857-864
41. Stanciu C., and Bennett J. Effects of posture on gastro-oesophageal reflux. Digestion 15 (1977) 104-109
42. Hamilton J.W., Boisen R.J., Yamamoto D.T., et al. Sleeping on a wedge diminishes exposure of the esophagus to refluxed acid. Dig Dis Sci 33 (1988) 518-522
43. Harvey R.F., Gordon P.C., Hadley N., et al. Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis. Lancet 2 (1987) 1200-1203
44. Khoury R.M., Camacho-Lobato L., Katz P.O., et al. Influence of spontaneous sleep positions on nighttime recumbent reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol 94 (1999) 2069-2073
45. van Herwaarden M.A., Katzka D.A., Smout A.J.P.M., et al. Effects of different recumbent positions on postprandial reflux in normal subjects. Am J Gastroenterol 95 (2000) 2731-2736
46. DeMeester T.R., Johnson L.F., Guy J.I., et al. Patterns of gastro-esophageal reflux in health and disease. Ann Surg 184 (1976) 459-470
47. Katz P.O., Anderson C., Khoury R.M., et al. Gastroesophageal reflux associated with nocturnal acid breakthrough on proton pump inhibitors. Aliment Pharmacol Ther 12 (1998) 1231-1234
48. Peghini P.L., Katz P.O., Bracy N.A., et al. Nocturnal recovery of gastric acid secretion with twice daily dosing of proton pump inhibitors. Am J Gastroenterol 93 (1998) 761-767
49. Suganuma N., Shigedo Y., Adachi H., et al. Association of gastroesophageal reflux disease with weight gain and apnea, and their disturbance on sleep. Psychiatry and Clinical Neurosciences 55 (2001) 255-256
50. Cohen J.A., Arain A., Harris P.A., et al. Surgical trial investigating nocturnal gastroesophageal reflux and sleep (STINGERS). Surg Endosc 17 (2003) 394-400
51. Johnson D.A., Orr W.C., Crawley J.A., et al. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial. Am J Gastroenterol 100 (2005) 1914-1922
52. Dimarino A.J., Banwait K.S., Eschinger E., et al. The effect of gastro-esopahgeal reflux and omeprazole on key sleep parameters. Aliment Pharmacol Ther 22 (2005) 325-329
53. Orr W.C., Goodrich S., and Robert J. The effect of acid suppression on sleep patterns and sleep-related gastro-oesophageal reflux. Aliment Pharmacol Ther 21 (2005) 103-108
54. Hattlebakk J., Katz P.O., Kuo B., et al. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily. Aliment Pharmacol Ther 12 (1998) 1235-1240
55. Pehlivanov N.D., Olyaee M., Sarosiek I., et al. Comparison of morning and evening administration of rabeprazole for gastro-esophageal reflux and nocturnal gastric acid breakthrough in patients with reflux disease: a double-blind cross-over study. Aliment Pharmacol Ther 18 (2003) 883-890
56. Katz P.O., Hatlebakk J.G., and Castell D. Gastric acidity and nocturnal breakthrough with twice-daily omeprazole or lansoprazole. Aliment Pharmacol Ther 14 (2000) 709-714
57. Ours T.M., Fackler W.K., Richter J.E., et al. Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. Am J Gastroenterol 98 (2003) 545-550
58. Peghini P.L., Katz P.O., and Castell D. Ranitidine controls nocturnal acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology 15 (1998) 1335-1339
59. Xue S., Katz P.O., Banerjee P., et al. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther 15 (2001) 1351-1356
60. Fackler W.K., Ours T.M., Vaezi M.F., et al. Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough. Gastroenterology 122 (2002) 625-632
61. Robinson M., Rodriguez-Stanley S., Ciociola A.A., et al. Control of nocturnal gastric acidity. A role for low dose bedtime ranitidine to supplement daily omeprazole. Dig Dis Sci 47 (2002) 265-273
62. Castell D., Bagin R., Goldlust B., et al. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-esophageal reflux disease. Aliment Pharmacol Ther 21 (2005) 1467-1474
63. Katz P.O., Koch F.K., Ballard E.D., et al. Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules, and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symtpoms. Aliment Pharmacol Ther 25 (2003) 197-205
64. Dickman R., Green C., Fass S.S., et al. Relationships between sleep quality and pH monitoring findings in persons with gastroesophageal reflux disease. J Clin Sleep Med 3 (2007) 505-513
65. Johnson L.F., and DeMeester T.R. Evaluation of elevation of the head of the bed, bethanechol, and antacid form tablets on gastroesophageal reflux. Dig Dis Sci 26 (1981) 673-680
66. Orr W.C., Craddock A., and Goodrich S. Acidic and non-acidic reflux during sleep under conditions of powerful acid suppression. Chest 131 (2007) 460-465
67. Shimatani T., Inoue M., Kuriowa T., et al. Rabeprazole 10 mg twice daily is superior to 20 mg once daily for night-time gastric acid suppression. Aliment Pharmacol Ther 19 (2004) 113-122
68. Orr W.C., and Harnish M. The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity. Aliment Pharmacol Ther 17 (2003) 1553-1558